Sun Pharmaceuticals Industries Limited is a global pharmaceutical company headquartered in Mumbai, India. Company has a profile of manufacturing API and formulations, and sells it over more than 40 countries. And with more than twenty destinations for its manufacturing unit. Every year Sun pharma grows a little bigger and has been listed in Forbes for Asia's fab 50 and World's top 100. Company is renowned for its high quality research facility, low impurity APIs, lesser cost products and worldwide reliability. With one of the biggest fermentation and chemical synthesis facility in India, it employees over 15k employees worldwide.
![[Image: sunp.jpg]](http://s24.postimg.org/ptbr8w22p/sunp.jpg)
Company was started in 1983 in Kolkata by Mr. Dilip Shanghvi with a manufacturing facility specialized in psychiatric drugs, within four years company expanded its specialty for Cardiology and Gastroenterology. Today company stands tall and proud with its expertise in cardiology, psychiatry, neurology, gastroenterology and diabetology. It also supplies APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, etc.
In this thread we will discuss about latest news and career updates of Sun Pharma.
Achieving another star in its success milestones Sun pharma has come up with a generic testosterone cypionate injection which is therapeutically equivalent to Pfizer Inc's Depo Testosterone injection. As per IMS MAT data company has estimated a $130 million market in the US. The injection is used for treatment of male fertility related issues and for replacement therapy in males with conditions and symptoms of deficiency or absence of endogenous testosterone.
The stock of Sun Pharmaceuticals hit a record high this year dominating the market capitalization over that of Dr Reddy’s Laboratories, Cipla and Lupin put together. Major revenue, profit growth and benefits are estimated from overseas acquisitions, currency depreciation and gigantic sales of its cancer drug Lipodox.
Along with this market capture company has also received the tentative approval for two significant abbreviated new drug applications (ANDAs)/generics for sale in the market and its unit, URL Pharma, recently hiked the selling price of a major selling drug in market.This, along with its recent acquisitions & mergers and extremely strong product pipeline, is likely to help Sun Pharma replicate its overall robust performance in financial year 2013.
The premium drug-maker policy and a robust business tactics takes all to receive Businees Leader in Pharmaceuticals. NDTV profit awards business awards with full market and financial survey, which truly reflects the winner. With other major awards in hand like CNBC most outstanding company of 2012, Forbes listed it in top 100 most innovative companies, Sun Pharma was awarded PHARMACEUTICAL COMPANY OF THE YEAR in 2011 by Frost & Sullivan India Healthcare Excellence Awards, Mr. Dilip S. Shanghvi was awarded WORLD ENTREPRENEUR OF THE YEAR by ERNST AND YOUNG 2010. And many more awards are in its accolades trunk and many more are on the way for 2013.
Click on the below jobs for more information on the post. Apply for the jobs by sending your resume to hrd@sunpharma.com, and do mention the code as per the job.
1. Business Development: Officer/Executive Business Development Mumbai, code SP043
2. Training Executive: Dadra, code SP030
3. Process Engineering: Manager/Senior Manager, Panoli (Gujarat), code SP029
4. Technology Transfer: Executive/Assistant Manager, Panoli (Gujarat), code SP028
![[Image: sun.png]](http://s21.postimg.org/jm7wmmkfb/sun.png)
We'll keep you updated with world's major companies updates and vacancies.
Company was started in 1983 in Kolkata by Mr. Dilip Shanghvi with a manufacturing facility specialized in psychiatric drugs, within four years company expanded its specialty for Cardiology and Gastroenterology. Today company stands tall and proud with its expertise in cardiology, psychiatry, neurology, gastroenterology and diabetology. It also supplies APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, etc.
In this thread we will discuss about latest news and career updates of Sun Pharma.
Achieving another star in its success milestones Sun pharma has come up with a generic testosterone cypionate injection which is therapeutically equivalent to Pfizer Inc's Depo Testosterone injection. As per IMS MAT data company has estimated a $130 million market in the US. The injection is used for treatment of male fertility related issues and for replacement therapy in males with conditions and symptoms of deficiency or absence of endogenous testosterone.
The stock of Sun Pharmaceuticals hit a record high this year dominating the market capitalization over that of Dr Reddy’s Laboratories, Cipla and Lupin put together. Major revenue, profit growth and benefits are estimated from overseas acquisitions, currency depreciation and gigantic sales of its cancer drug Lipodox.
Along with this market capture company has also received the tentative approval for two significant abbreviated new drug applications (ANDAs)/generics for sale in the market and its unit, URL Pharma, recently hiked the selling price of a major selling drug in market.This, along with its recent acquisitions & mergers and extremely strong product pipeline, is likely to help Sun Pharma replicate its overall robust performance in financial year 2013.
The premium drug-maker policy and a robust business tactics takes all to receive Businees Leader in Pharmaceuticals. NDTV profit awards business awards with full market and financial survey, which truly reflects the winner. With other major awards in hand like CNBC most outstanding company of 2012, Forbes listed it in top 100 most innovative companies, Sun Pharma was awarded PHARMACEUTICAL COMPANY OF THE YEAR in 2011 by Frost & Sullivan India Healthcare Excellence Awards, Mr. Dilip S. Shanghvi was awarded WORLD ENTREPRENEUR OF THE YEAR by ERNST AND YOUNG 2010. And many more awards are in its accolades trunk and many more are on the way for 2013.
Click on the below jobs for more information on the post. Apply for the jobs by sending your resume to hrd@sunpharma.com, and do mention the code as per the job.
1. Business Development: Officer/Executive Business Development Mumbai, code SP043
2. Training Executive: Dadra, code SP030
3. Process Engineering: Manager/Senior Manager, Panoli (Gujarat), code SP029
4. Technology Transfer: Executive/Assistant Manager, Panoli (Gujarat), code SP028
We'll keep you updated with world's major companies updates and vacancies.
![[+]](https://www.biotechnologyforums.com/images/netpen-pro/collapse_collapsed.png)